Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Journal of Neurology and Neurorehabilitation Research (2024) Volume 9, Issue 3

Mitochondrial Disorders in Children: Clinical Features and Management Strategies

Kathryn Gillingwater *

Department of Pediatrics, Medical College of Wisconsin, USA

*Corresponding Author:
Kathryn Gillingwater
Department of Pediatrics, Medical College of Wisconsin, USA
E-mail: gillingwater@wmc.us.in

Received: 29-Apr-2024, Manuscript No. JNNR-24-137852; Editor assigned: 30-Apr-2024, PreQC No. JNNR-24-137852 (PQ); Reviewed: 15-May-2024, QC No. JNNR-24-137852; Revised: 20-May-2024, Manuscript No. JNNR-24-137852(R); Published: 27-May-2024, DOI: 10.35841/aajnnr-9.3.209

Citation: : Gillingwater K. Mitochondrial Disorders in Children: Clinical Features and Management Strategies. J Neurol Neurorehab Res.2024;9(3):209

Introduction

Mitochondrial disorders are a diverse group of genetic conditions that result from dysfunction in the mitochondria, the energy-producing structures within cells. These disorders can manifest at any age but often present during childhood. Given the essential role of mitochondria in cellular energy production, mitochondrial disorders can affect multiple organ systems, leading to a wide range of clinical features. This article provides an overview of the clinical features of mitochondrial disorders in children and discusses current management strategies [1].

Neurological Symptoms: Muscle Weakness and Hypotonia: One of the most frequent symptoms, often presenting as muscle weakness or decreased muscle tone. Developmental Delay: Delays in achieving developmental milestones, such as sitting, walking, or talking. Seizures: Various types of seizures, including myoclonic, tonic-clonic, or absence seizures, may occur. Ataxia: Difficulty with coordination and balance, leading to an unsteady gait [2].

Ophthalmological Symptoms: Optic Atrophy: Degeneration of the optic nerve, leading to vision loss. Retinal Degeneration: Progressive loss of vision due to damage to the retina. Cardiovascular Symptoms: Cardiomyopathy: A condition where the heart muscle becomes weakened and enlarged, leading to heart failure. Conduction Defects: Problems with the electrical signals that control the heartbeat, leading to arrhythmias [3].

Gastrointestinal Symptoms: Feeding Difficulties: Poor feeding, vomiting, and failure to thrive. Liver Dysfunction: Ranging from mild liver enzyme abnormalities to severe liver failure. Endocrinological Symptoms: Diabetes Mellitus: A common complication in mitochondrial disorders, often requiring insulin therapy. Growth Hormone Deficiency: Leading to short stature and delayed growth [4].

Hematological Symptoms: Anemia: Often seen in children with mitochondrial disorders, requiring frequent monitoring and treatment. Diagnosing mitochondrial disorders can be challenging due to their clinical variability. A comprehensive approach includes: Clinical Evaluation: Detailed medical history and thorough physical examination to identify the range of symptoms and affected systems [5].

Blood and Urine Tests: To detect metabolic abnormalities such as elevated lactate and pyruvate levels. Muscle Biopsy: Analysis of muscle tissue for mitochondrial abnormalities, including decreased enzyme activities of the respiratory chain complexes [6].

Mitochondrial DNA (mtDNA) Testing: Identifies mutations in the mtDNA, which is inherited maternally. Nuclear DNA Testing: Identifies mutations in nuclear genes that affect mitochondrial function. Neuroimaging: MRI and MRS: Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) to detect structural and metabolic abnormalities in the brain [7].

Physical and Occupational Therapy: Rehabilitation: To maintain muscle strength, improve coordination, and enhance daily functioning. Assistive Devices: Use of orthotic devices, wheelchairs, or other mobility aids as needed [8].

Regular Monitoring: Frequent assessments by a multidisciplinary team, including neurologists, cardiologists, endocrinologists, and ophthalmologists. Acute Interventions: Prompt treatment of infections and metabolic crises to prevent further mitochondrial damage [9].

Gene Therapy: Research is ongoing to develop gene therapy approaches that could correct specific genetic defects in mitochondrial disorders. Mitochondrial Replacement Therapy (MRT): A novel technique that replaces faulty mitochondria with healthy ones from a donor, though currently experimental and ethically debated [10].

Conclusion

Mitochondrial disorders in children present with a wide range of clinical features, reflecting the central role of mitochondria in cellular energy production. Accurate diagnosis often requires a combination of clinical evaluation, biochemical tests, genetic testing, and neuroimaging. While there is no cure for mitochondrial disorders, advancements in management strategies, including nutritional support, pharmacological treatments, physical therapy, and emerging gene therapies, offer hope for improving the quality of life and prognosis for affected children. Multidisciplinary care, supportive services, and ongoing research are essential to address the complex needs of these patients and their families.

References

  1. Kovacic K, Li BU. Cyclic vomiting syndrome: A narrative review and guide to management. Headache. 2021;61(2):231-43.

    2. Indexed at, Google Scholar, Cross Ref

  2. Aimo A, Morfino P, Arzilli C, et al. Disease features and management of cardiomyopathies in women. Heart Fail Rev. 2024:1-2.

    3. Indexed at, Google Scholar, Cross Ref

  3. Romo L, Gold NB, Walker MA. Endocrine features of primary mitochondrial diseases. Curr Opin Endocrinol Diabetes Obes. 2024;31(1):34-42.

    4. Indexed at, Google Scholar, Cross Ref

  4. Cook KM, Shen H, McKelvey KJ, et al. Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas. Int J Mol Sci. 2021;22(14):7265.

    5. Indexed at, Google Scholar, Cross Ref

  5. Yu-Wai-Man P, Votruba M, Moore AT, et al. Treatment strategies for inherited optic neuropathies: past, present and future. Eye (Lond). 2014;28(5):521-37.

    6. Indexed at, Google Scholar, Cross Ref

  6. Ng YS, Bindoff LA, Gorman GS, et al. Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol. 2021;20(7):573-84.

    7. Indexed at, Google Scholar, Cross Ref

  7. Koopman WJ, Beyrath J, Fung CW, et al. Mitochondrial disorders in children: toward development of small?molecule treatment strategies. EMBO Mol Med. 2016;8(4):311-27.

    8. Indexed at, Google Scholar, Cross Ref

  8. Frye RE. Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 2015;47:147-57.

    9. Indexed at, Google Scholar, Cross Ref

  9. Nascimento A, Ortez C, Jou C, et al. Neuromuscular manifestations in mitochondrial diseases in children. Semin Pediatr Neurol. 2016; 23(4):290-305.

    10. Indexed at, Google Scholar, Cross Ref

  10. Finsterer J, Zarrouk-Mahjoub S, Daruich A. The eye on mitochondrial disorders. J Child Neurol. 2016;31(5):652-62.

    11. Indexed at, Google Scholar, Cross Ref

Get the App